Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.50%||163.45||0.7%||$1097.89m|
|MRK||Merck & Co., Inc.||1.10%||76.41||0.7%||$1035.99m|
|LLY||Eli Lilly & Co.||7.28%||232.90||1.1%||$961.74m|
|BMY||Bristol-Myers Squibb Co.||0.90%||65.85||1.0%||$630.59m|
|CNST||Constellation Pharmaceuticals, Inc.||0.12%||33.80||0.0%||$110.91m|
|RPRX||Royalty Pharma Plc||1.99%||43.03||0.2%||$106.04m|
OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.